Neuronetics, Inc. (NASDAQ:STIM) Q4 2025 Earnings Call Transcript March 17, 2026 Neuronetics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.10553. Operator: Ladies and ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

Bahwan CyberTek (BCT), a global provider of AI-driven digital transformation solutions, today announced the launch of AIgeniX, its next-generation Agentic AI platform designed to help enterprises ...

Q4 2025 Earnings Call March 16, 2026 8:00 AM EDTCompany ParticipantsKristal Li - Investor Relations ManagerYan Li - Chairman, ...

Today, let's look at four consumer stocks in India that could be worth adding to your watchlist. First on the list is Varun Beverages (VBL). VBL has a long-standing association with PepsiCo, spanning ...

Welcome to Identiv's presentation of its Fourth Quarter and Fiscal Year 2025 Earnings Call. My name is John, and I will be your operator this afternoon. Joining us for today's presentation are the ...

TIC Solutions, Inc. (NYSE: TIC) ("TIC Solutions" or the "Company"), a leading provider of tech-enabled Testing, Inspection, ...

Tempus AI, Inc. Class A ((TEM)) has held its Q4 earnings call. Read on for the main highlights of the call. Tempus AI, Inc. used its latest earnings call to underscore a broadly upbeat outlook, ...

DELRAY BEACH, Fla., March 10, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Testing, Inspection and Certification (TIC) Market is expected to grow from USD 254.41 billion in 2026 to USD ...

Generated record revenue of approximately $120 million for full-year 2025, driven by PAC performance Reported Adjusted EBITDA(1) of $13 million, representing 26% improvement year-over-year Provided ...

MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF) announces a brokered private placement offering of up to $20 million to advance natural hydrogen exploration in Saskatchewan and critical minerals ...

Record full-year total revenue and AVISE® CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume ...